Hixon Zuercher LLC lifted its stake in shares of Amdocs Limited (NASDAQ:DOX – Free Report) by 3.1% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 38,747 shares of the technology company’s stock after acquiring an additional 1,167 shares during the period. Hixon Zuercher LLC’s holdings in Amdocs were worth $3,299,000 at the end of the most recent reporting period.
A number of other institutional investors also recently modified their holdings of DOX. Private Trust Co. NA lifted its position in shares of Amdocs by 62.9% during the 3rd quarter. Private Trust Co. NA now owns 303 shares of the technology company’s stock valued at $27,000 after acquiring an additional 117 shares during the period. Brooklyn Investment Group acquired a new position in shares of Amdocs during the 3rd quarter valued at $28,000. Catalyst Capital Advisors LLC acquired a new position in shares of Amdocs during the 3rd quarter valued at $55,000. GAMMA Investing LLC lifted its position in shares of Amdocs by 115.1% during the 3rd quarter. GAMMA Investing LLC now owns 800 shares of the technology company’s stock valued at $70,000 after acquiring an additional 428 shares during the period. Finally, Meeder Asset Management Inc. acquired a new position in shares of Amdocs during the 3rd quarter valued at $77,000. Institutional investors and hedge funds own 92.02% of the company’s stock.
Amdocs Stock Performance
Shares of DOX stock opened at $87.46 on Friday. Amdocs Limited has a 12 month low of $74.41 and a 12 month high of $94.04. The company has a current ratio of 1.20, a quick ratio of 1.20 and a debt-to-equity ratio of 0.21. The firm has a market capitalization of $9.87 billion, a PE ratio of 20.63, a price-to-earnings-growth ratio of 1.44 and a beta of 0.71. The firm has a fifty day simple moving average of $85.87 and a two-hundred day simple moving average of $86.25.
Amdocs Announces Dividend
Wall Street Analyst Weigh In
A number of research analysts recently issued reports on DOX shares. Barclays dropped their target price on shares of Amdocs from $113.00 to $111.00 and set an “overweight” rating on the stock in a research report on Thursday, November 14th. StockNews.com lowered shares of Amdocs from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, January 14th. Finally, Oppenheimer boosted their price target on shares of Amdocs from $98.00 to $105.00 and gave the company an “outperform” rating in a research note on Wednesday, November 13th. One equities research analyst has rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $101.20.
Read Our Latest Research Report on Amdocs
Amdocs Company Profile
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Featured Articles
- Five stocks we like better than Amdocs
- What Is WallStreetBets and What Stocks Are They Targeting?
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- How to Use the MarketBeat Dividend Calculator
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Want to see what other hedge funds are holding DOX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amdocs Limited (NASDAQ:DOX – Free Report).
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.